Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(2 sites)
United States
Children's Healthcare fo Atlanta at Hughes Spalding, Atlanta, Georgia Children's Healthcare of Atlanta at Arthur M. Blank Hospital, Atlanta, Georgia